AME and Wolters Kluwer aim to expand access to global medical research through new collaboration

The agreement broadens the reach of nearly 50 Open Access titles, contributing globally to over 5,000 articles

October 2, 2025 — Wolters Kluwer Health announced a new collaboration with AME Publishing Company, an Open Access publisher specializing in medical journals and books, headquartered in Hong Kong, China.

Read More>>

The First Impact Factor for ABS: 0.9

We are pleased to announce that the Annals of Breast Surgery (ABS) has attained its first impact factor for the 2024 citation year: 0.9.

We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, Authors, and Reviewers for their significant contributions.

Read More>>

Annals of Breast Surgery 2024 CiteScore Released: 1.2

We are pleased to announce that the Annals of Breast Surgery (ABS) has achieved its 2024 CiteScore: 1.2, ranking 353 out of 568 journals in the Surgery category. This milestone underscores our ongoing commitment to publishing impactful research in the field.

Read More>>

Reviewer of the Month (2026)

In 2026, ABS reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Read More>>

Interviews with Editorial Board Members

ABS features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Read More>>

Interviews with Outstanding Authors (2025)

In 2025, many authors bring new findings, practical information on the diagnosis and treatment of conditions related to breast diseases to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspectives and insightful views as authors.

Read More>>

A novel surgical approach to treat lymphangioma of the breast and prevent seroma—a case report

Pathology, macroscopy (A,B) and microscopy (C,D). (C,D) The staining method is haematoxylin and eosin with the insert on 3C as stated (D2-40 immunohistochemistry), and the width of pictures C&D is equivalent to 2.2 mm.

Read More>>

Metastatic breast involvement from Merkel cell tumour: a case report

PET/CT image showing the gastric ventricle as a possible focus of primary tumour. PET/CT, positron emission tomography/computed tomography.

Read More>>

Phyllodes breast tumours: diagnostic challenges, surgical approaches, and post-treatment considerations—a case report on insidious clinical presentation, progression, histopathological and radiological tumour transformation

Case 1. (A) Magnetic resonance imaging of the breast, sagittal section, showing the phyllodes breast tumour and a breast implant posterior to the tumour. (B) Preoperative clinical presentation with an enlarged right breast with a tumour mass estimated to 30 cm in diameter. (C) A positron emission tomography and computed tomography, axial section, showing the phyllodes breast tumour measuring 12 cm × 12 cm × 13 cm in diameter with no deep invasion of the underlying pectoralis muscle. The breast implant is visualised posterior to the tumour. (D) Perioperative total mastectomy of the right including partial resection of the pectoralis muscle. (E) The defect measuring 30 cm × 25 cm after excision. (F) Four-month follow-up and postoperative result.

Read More>>

Cancer recurrence in routine histopathology of mastectomy scars during breast reconstruction: a systematic review

PRISMA flowchart of the study selection process.

Read More>>

Comparative analysis of sentinel lymph node localization techniques: evaluating Magtrace (superparamagnetic iron oxide nanoparticle) against conventional technetium-99m (Tc-99m) and blue dye methods for breast cancer, and assessment of patient satisfaction

Patient satisfaction questionnaire.

Read More>>